Treating dexamethasone-induced mood disorders in children with leukemia

Pediatric Blood and Cancer

Volumn 51, Issue 1, 2008, Pages 147-

  Joshi, Divya Devi ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; DEXAMETHASONE; SEROTONIN UPTAKE INHIBITOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; CASE REPORT; CHILDHOOD LEUKEMIA; CLINICAL FEATURE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG TOLERABILITY; FEMALE; HUMAN; LETTER; LOW DRUG DOSE; MOOD DISORDER; MULTIPLE CYCLE TREATMENT; PATIENT COUNSELING; PRESCHOOL CHILD; PRIORITY JOURNAL; SUICIDE; SYMPTOMATOLOGY; TREATMENT RESPONSE;

CHILD, PRESCHOOL; CITALOPRAM; DEXAMETHASONE; FEMALE; HUMANS; LEUKEMIA; MOOD DISORDERS;

EID: 44149118661     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21518     Document Type: Letter

References (6)

1. Wada K, Yamada N, Suzuki H, et al. Recurrent cases of corticosteroid-induced mood disorder: Clinical characteristics and treatment. J Clin Psychiatry 2001;62:57-58 (Comment).
2. Drigan R, Spirito A, Gelber RD. Behavioral effects of corticosteroids in children with acute lymphoblastic leukemia. Med Pediatr Oncol 1992;20:13-21.
3. McGrath P, Pitcher L. "Enough is enough": Qualitative findings on the impact of dexamethasone during reinduction/consolidation for paediatric acute lymphoblastic leukemia. Support Care Cancer 2002;10:146-155.
4. Pretorius E. Corticosteroids, depression and the role of serotonin. Rev Neurosci 2004;15:109-116.
5. Hetrick S, Merry S, McKenzie J, et al. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. Cochrane Database Syst Rev 2007;3:CD004851.
6. DeJong M, Fombonne E. Citalopram to treat depression in pediatric oncology. J Child Adolesc Psychopharmacol 2007;17:371-377.